ACTG Launches A5383, Clinical Trial Evaluating Potential Immunologic Benefits Of Treating Asymptomatic CMV In People Living With HIV

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://actgnetwork.org/2022/04/22/actg-launches-a5383-clinical-trial-evaluating-potential-immunologic-benefits-of-treating-asymptomatic-cmv-in-people-living-with-hiv/
Research Institution
ACTG
Short Title
ACTG Launches A5383, Clinical Trial Evaluating Potential Immunologic Benefits Of Treating Asymptomatic CMV People Living With HIV
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck